Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001840
Filing Date
2025-03-31
Accepted
2025-03-31 17:10:46
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2048254
2 ex4-13.htm EX-4.13 60962
3 ex19-1.htm EX-19.1 119116
4 ex23-1.htm EX-23.1 3514
5 ex31-1.htm EX-31.1 18043
6 ex31-2.htm EX-31.2 18129
7 ex32-1.htm EX-32.1 7310
8 ex32-2.htm EX-32.2 7632
  Complete submission text file 0001641172-25-001840.txt   8408063

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE biaf-20241231.xsd EX-101.SCH 53176
10 XBRL CALCULATION FILE biaf-20241231_cal.xml EX-101.CAL 86089
11 XBRL DEFINITION FILE biaf-20241231_def.xml EX-101.DEF 231508
12 XBRL LABEL FILE biaf-20241231_lab.xml EX-101.LAB 508272
13 XBRL PRESENTATION FILE biaf-20241231_pre.xml EX-101.PRE 394243
91 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1169909
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41463 | Film No.: 25794875
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)